2 highlighted the critical role of the innate immune response in autoimmunity and other inflammatory conditions 4 . We anticipate that our novel findings will lead to the discovery of therapeutic targets for this disease and other inflammatory diseases mediated by IL-23.
Celiac disease (CD) is a chronic inflammatory disorder of the small intestine triggered by dietary glutens in genetically susceptible individuals 1 . More than a decade of research has defined the T cell response to gluten-derived gliadin peptides in CD, yet the early events that initiate its activation are not well understood 3, 5, 6 . Clearly, the compromised intestinal epithelial barrier that characterizes CD allows gliadin access to the intestinal submucosa, where it must be acquired and processed by antigen presenting cells (APC) for presentation and activation of gliadin-specific CD4 + T cells. While augmented levels of zonulin and potent inflammatory cytokines IL-1β and TNFα have all been reported to increase intestinal permeability by disrupting the integrity of tight junctions in individuals with CD and other forms of inflammatory bowel disease (IBD), the precise mechanisms involved remain to be determined [7] [8] [9] .
A dynamic relationship between intestinal epithelial cells (IEC) and dendritic cells (iDC) regulates the processes of immunologic tolerance to harmless food and commensal antigens and adaptive immunity to pathogens 10 In order to demonstrate that production of these potent mediators depended on gliadin exposure, dose response curves were generated with PTG or β-glucan, an agent known to activate the IL-23 pathway. Both stimuli induced dose-dependent production of IL-1β and IL-23, although PTG proved to be far more effective as evidenced by detectable levels of IL-23 achieved with 100μg/ml versus 500μg/ml of β-glucan ( Figure   1b ). These stimulatory effects of PTG were not due to endotoxin contamination, since the presence of LPS in this preparation of PTG was ruled out in earlier studies 29 . Reagents. Gliadin was prepared by enzymatic digestion as described previously 29 . The presence of contaminating endotoxin in gliadin was determined by Limulus amebocyte assay per the manufacturers' instructions. 100mg of β-D-glucan from barley (Sigma) was dissolved in 600ul 95%EtOH followed by 9mL distilled water. The resultant slurry was stirred vigorously at 100°C for 3 minutes, allowed to cool, and stored at 10mg/ml at 4°C until used. 25 overlapping 20mers spanning the sequence of α-gliadin were synthesized and purified >95% at the University of Maryland Biopolymer Lab, and with and without PTG, β-glucan, 5ng/ml rhIL-1β, or 10μg/ml pooled synthetic 20mers of α-gliadin in 96 well U-bottom plates (Denville Scientific Inc.) at 37 °C in 5% CO 2 for 6, 24, 48, or 72h. Alternatively, 10 6 PBMC/ml were incubated with 0.5μg/ml rhIL1ra at 37 °C in 5% CO 2 for 1h then cultured with and without 100μg/ml PTG or 500μg/ml β-glucan for an additional 20h. Cell-free culture supernatants were harvested for cytokine and chemokine analysis.
Elutriated monocyte cultures. 5 x 10 5 monocytes/ml were cultured in cRPMI with and without 100μg/ml PTG, 100μg/ml β-glucan, or 0.5-50ng/ml rhIL-1β in 96 well Ubottom plates at 37 °C in 5% CO 2 for 20h. Alternatively, 5 x 10 5 monocytes/ml were incubated with 0.5μg/ml rhIL-1ra at 37 °C in 5% CO 2 for 1h then cultured with and without 100μg/ml PTG or β-glucan for an additional 20h. Cell-free culture supernatants were harvested for cytokine and chemokine analysis.
Cytokine & chemokine analysis. Cell-free culture supernatants were analyzed for IL-1β, IL-1ra, IL-6, IL-12p70, IFNγ, TNFα (Bio-Plex Cytokine Assay kit, Bio-Rad) or IL- Error bars indicate + s.d.
